Documentos de Murenzi G. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área temáticas: "Problemas sociales y servicios a grupos"

Subtipo de publicación

Publisher

Journal of the International AIDS Society(2)

Clinical Infectious Diseases(1)

Área temáticas

Enfermedades(3)

Medicina y salud(2)

Medicina forense; incidencia de enfermedades(1)

Área de conocimiento

Epidemiología(1)

Año de Publicación

Origen

Palabras Claves

HIV integrase inhibitors(2)

antiretroviral agents(2)

Cohort Studies(1)

HIV care continuum(1)

Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018

Abstract: Introduction: The Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) is

Palabras claves:

ÁFRICA, ARV, Cohort Studies, HIV care continuum, HIV epidemiology, Low- and middle-income countries

Addison D., Adedimeji A., Adedimeji A.A., Ajeh R., Akele C., Amadou D., Anastos K., Ayinkamiye N., Balkissou A.D., Baransaka E., Barasukana P., Benekigeri C., Benwi M., Biziragusenyuka J., Brazier E., Bukuru H., Busingye L., Butera A.M., Diafouka M., Dilorenzo M., Dzudie A., Ekat M.H., Ekembe C., Ewanoge A.N., Fuhngwa N., Gasana J., Gateretse P., Habarurema E., Habiryayo T., Hoover D.R., Igirimbabazi J., Ingabire C., Ingabire M.G., Jones H., Kabahizi J., Kabanda E., Kagimbana J.C., Kankindi C., Kanyabwisha F., Kelvin E.A., Kendowo E., Kim H.Y., Kitetele F., Kubwimana G., Kulkarni S.G., Lelo P., Mafou A., Manirakiza M., Matthew L. Romo, Mbuh A., Mbuh T., Moki C., Muhayimpundu R., Muhoza B., Mukamusana D., Munezero A.M.M., Munezero J., Munyaneza A., Murchison L., Murenzi G., Musabyimana F., Musaninyange J., Mwiza F., Nahimana T., Nash D., Ndamijimana E., Ndikumwenayo F., Ndoli Y., Ndumuhire J., Nforniwe D.N., Ngamani M.L., Ngassam E., Nitereka V., Niyongabo T., Njie K.T., Nkome V., Nsanzimana S., Nsonde D., Nyirabahutu M.G., Nyiraneza M.L., Okitolonda E.W., Pélagie N., Remera E., Ross J., Rwibasira G.N., Sandjong F., Shi Q., Shyaka C., Sinayobye J.d.A., Tabala M., Tchassem E., Tsi K.A., Tuyisenge L., Tuyisenge P., Twizere C., Umumararungu E., Uwakijijwe B., Uwamahoro O., Yone E.W.P., Yotebieng M.

Viral Load Status Before Switching to Dolutegravir-Containing Antiretroviral Therapy and Associations With Human Immunodeficiency Virus Treatment Outcomes in Sub-Saharan Africa

Abstract: Background: Dolutegravir is being rolled out globally as part of preferred antiretroviral therapy (A

Palabras claves:

antiretroviral agents, clinical decision-making, HIV integrase inhibitors, prognosis, Viral load

Diero L., Edwards J.K., Kasozi C., Kelvin E.A., Lelo P., Matthew L. Romo, Murenzi G., Musick B.S., Nash D., Odhiambo F., Semeere A.S., Sohn A.H., Urassa M., Wools-Kaloustian K.K., Wyka K.

Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa

Abstract: Introduction: Dolutegravir is being scaled up globally as part of antiretroviral therapy (ART), but

Palabras claves:

antiretroviral agents, antitubercular agents, drug interactions, HIV integrase inhibitors, Observational Study, rifampin

Brazier E., Chimbetete C., De Waal R., Diero L., Dzudie A., Ezechi O.C., Fenner L., Kunzekwenyika C., Lelo P., Mahambou-Nsondé D., Matthew L. Romo, Muhairwe J.A., Murenzi G., Muyindike W.R., Nash D., Rafael I., Sekaggya-Wiltshire C., Shah N.S., Tiendrebeogo T., Twizere C., Wools-Kaloustian K.K., Yotebieng M.